Stockscreener 앱 받기
6.99
7.54%
0.49
시간 외 거래:
7.33
0.34
+4.86%
전일 마감가:
$6.50
열려 있는:
$6.68
하루 거래량:
291.66K
Relative Volume:
4.88
시가총액:
$261.62M
수익:
$4.71M
순이익/손실:
$-46.77M
주가수익비율:
-4.1627
EPS:
-1.6792
순현금흐름:
$-60.34M
1주 성능:
-12.62%
1개월 성능:
-29.47%
6개월 성능:
-22.59%
1년 성능:
-44.12%
1일 변동 폭
$6.45
$7.3513
1주일 범위
$6.30
$8.08
52주 변동 폭
$6.30
$12.79
Nyxoah Sa Stock (NYXH) Company Profile
NYXH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
6.99 | 261.62M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
494.61 | 177.21B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
221.59 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
89.61 | 44.32B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
213.35 | 31.33B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
31.35 | 16.08B | 17.28B | 108.00M | 391.00M | 0.20 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-31 | 개시 | H.C. Wainwright | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2022-04-21 | 개시 | Oppenheimer | Outperform |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2021-12-21 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-07-28 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Nyxoah Sa 주식(NYXH)의 최신 뉴스
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - GlobeNewswire Inc.
Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A.NYXH - PR Newswire
Oppenheimer maintains $13 target on Nyxoah shares post-FDA talks - Investing.com India
Nyxoah S.A. Investors: Company Investigated By The Portnoy Law Firm - MENAFN.com
HC Wainwright Comments on Nyxoah’s Q1 Earnings (NASDAQ:NYXH) - Defense World
Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire
HC Wainwright Lowers Nyxoah (NASDAQ:NYXH) Price Target to $15.00 - Defense World
Nyxoah SA: A Medical Technology Company with a Big Loss - RagingBull
Nyxoah announces FDA approvable letter for Genio pre-market approval application - TipRanks
Nyxoah Says FDA Issues Approvable Letter for Genio System - Marketscreener.com
FDA Issues Approvable Letter For Nyxoah's Genio® System - TradingView
Stifel Nicolaus Has Lowered Expectations for Nyxoah (NASDAQ:NYXH) Stock Price - Defense World
Stifel cuts Nyxoah stock price target to $15, maintains Buy By Investing.com - Investing.com Canada
Nyxoah SA (NYXH) Reports Q4 Loss, Lags Revenue Estimates - MSN
(NYXH) Investment Analysis - Stock Traders Daily
Stifel cuts Nyxoah stock price target to $15, maintains Buy - Investing.com
Nyxoah S.A. (NASDAQ:NYXH) Q4 2024 Earnings Call Transcript - Insider Monkey
H.C. Wainwright maintains Buy on Nyxoah shares, $17 target - Investing.com
Nyxoah SA (NYXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic US ... By GuruFocus - Investing.com Canada
Nyxoah Reports 2024 Financial Results and U.S. Launch Plans - TipRanks
Nyxoah Sa’s Earnings Call: Efficacy and Expansion - TipRanks
Nyxoah Reports Strong Q4 Growth as Sleep Apnea Device Nears FDA Green Light - Stock Titan
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results - The Manila Times
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 - The Manila Times
Critical Survey: Nyxoah (NASDAQ:NYXH) vs. PolyPid (NASDAQ:PYPD) - Defense World
Nyxoah (NYXH) to Release Quarterly Earnings on Thursday - Defense World
Transparency Notification: Vestal Point Capital’s Stake in Nyxoah - PanAsiaBiz
(NYXH) Investment Report - news.stocktradersdaily.com
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - The Manila Times
Sleep Apnea Innovator Nyxoah Takes Center Stage at Major Healthcare Conference - StockTitan
Nyxoah (NYXH) to Release Quarterly Earnings on Tuesday - Defense World
Nyxoah (NYXH) Projected to Post Earnings on Tuesday - MarketBeat
Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) versus Nyxoah (NASDAQ:NYXH) Critical Review - Defense World
(NYXH) On The My Stocks Page - Stock Traders Daily
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East - GlobeNewswire
Revolutionary Sleep Apnea Treatment Crosses Borders: Inside Genio's Middle East Launch - StockTitan
Nyxoah Launches Genio Therapy in Middle East with First UAE Implantation - TipRanks
Nyxoah (NASDAQ:NYXH) Stock Price Up 0.6%Here's What Happened - MarketBeat
Tri Pointe Homes (TPH) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Nyxoah (NASDAQ:NYXH) Shares Up 0.6% – Here’s What Happened - Defense World
Nyxoah to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Environmental Expert
(NYXH) Trading Report - Stock Traders Daily
Trend Tracker for (NYXH) - Stock Traders Daily
Cantor Fitzgerald Predicts Nyxoah FY2025 Earnings - Defense World
NYXHNyxoah SA Ordinary Shares Latest Stock News & Market Updates - StockTitan
Nyxoah Receives Transparency Notification from BlackRock - TipRanks
Nyxoah Sa (NYXH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.94%
1.87%
자본화:
|
볼륨(24시간):